Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 22 - Number 12

Review Article (Mini-Review)

Antibiotic Adjuvants: A Promising Approach to Combat Multidrug Resistant Bacteria

, 22(12): 1334 - 1345

Namita Sharma, Anil K. Chhillar*, Sweety Dahiya, Pooja Choudhary, Aruna Punia and Prity Gulia

DOI: 10.2174/1389450122666210120084406

Review Article (Mini-Review)

Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance

, 22(12): 1346 - 1356

Dinesh S. Moirangthem and Laishram Surbala*

DOI: 10.2174/1389450121999201202110303

Review Article (Mini-Review)

Potential Role of In Vitro-In Vivo Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs

, 22(12): 1357 - 1375

Mohamed S.T.A. Azeeze*, Shanthi B. Santhosh, Murugesan S. Manjari and Subramania N. Meyyanathan

DOI: 10.2174/1389450121999201113110433

Review Article

Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease

, 22(12): 1376 - 1403

Suvadeep Mal, Udita Malik, Dilipkumar Pal* and Abhishek Mishra

DOI: 10.2174/1389450121999201230203709

Review Article

Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease

, 22(12): 1404 - 1423

Ishnoor Kaur, Arun Kumar*, Tapan Behl and Dhruv Setia

DOI: 10.2174/1389450122999210104205018

Review Article

Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes

, 22(12): 1424 - 1436

Hafsa Qadri, Abdul H. Shah* and Manzoor Mir*

DOI: 10.2174/1389450121666201228123212

Review Article

Recent Advances in the Discovery of GSK-3 Inhibitors from Synthetic Origin in the Treatment of Neurological Disorders

, 22(12): 1437 - 1462

Supriyo Saha*, Dilipkumar Pal and Satish B. Nimse

DOI: 10.2174/1389450122666210120143953


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog